Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Oxford Maternal and Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, United Kingdom.
JAMA Pediatr. 2021 May 1;175(5):483-493. doi: 10.1001/jamapediatrics.2020.6087.
The etiologic complexities of preterm birth remain inadequately understood, which may impede the development of better preventative and treatment measures.
To examine the association between specific preterm-birth phenotypes and clinical, growth, and neurodevelopmental differences among preterm newborns compared with term newborns up to age 2 years.
DESIGN, SETTING, AND PARTICIPANTS: The INTERBIO-21st study included a cohort of preterm and term newborn singletons enrolled between March 2012 and June 2018 from maternity hospitals in 6 countries worldwide who were followed up from birth to age 2 years. All pregnancies were dated by ultrasonography. Data were analyzed from November 2019 to October 2020.
EXPOSURES/INTERVENTIONS: Preterm-birth phenotypes.
Infant size, health, nutrition, and World Health Organization motor development milestones assessed at ages 1 and 2 years; neurodevelopment evaluated at age 2 years using the INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA) tool.
A total of 6529 infants (3312 boys [50.7%]) were included in the analysis. Of those, 1381 were preterm births (mean [SD] gestational age at birth, 34.4 [0.1] weeks; 5148 were term births (mean [SD] gestational age at birth, 39.4 [0] weeks). Among 1381 preterm newborns, 8 phenotypes were identified: no main maternal, fetal, or placental condition detected (485 infants [35.1%]); infections (289 infants [20.9%]); preeclampsia (162 infants [11.7%]); fetal distress (131 infants [9.5%]); intrauterine growth restriction (110 infants [8.0%]); severe maternal disease (85 infants [6.2%]); bleeding (71 infants [5.1%]); and congenital anomaly (48 infants [3.5%]). For all phenotypes, a previous preterm birth was a risk factor for recurrence. Each phenotype displayed differences in neonatal morbidity and infant outcomes. For example, infants with the no main condition detected phenotype had low neonatal morbidity but increased morbidity and hospitalization incidence at age 1 year (odds ratio [OR], 2.2; 95% CI, 1.8-2.7). Compared with term newborns, the highest risk of scoring lower than the 10th centile of INTER-NDA normative values was observed in the fine motor development domain among newborns with the fetal distress (OR, 10.6; 95% CI, 5.1-22.2) phenotype.
Results of this study suggest that phenotypic classification may provide a better understanding of the etiologic factors and mechanisms associated with preterm birth than continuing to consider it an exclusively time-based entity.
早产的病因复杂性仍未得到充分理解,这可能会阻碍更好的预防和治疗措施的发展。
研究特定的早产表型与早产儿和足月儿在 2 岁之前的临床、生长和神经发育差异之间的关系。
设计、地点和参与者:INTERBIO-21 研究是一项队列研究,纳入了 2012 年 3 月至 2018 年 6 月期间来自全球 6 个国家的妇产科医院的单胎早产儿和足月儿,从出生开始随访至 2 岁。所有妊娠均通过超声确定胎龄。数据分析于 2019 年 11 月至 2020 年 10 月进行。
暴露/干预:早产表型。
1 岁和 2 岁时婴儿的大小、健康、营养和世界卫生组织运动发育里程碑;2 岁时使用 INTERGROWTH-21 神经发育评估(INTER-NDA)工具进行神经发育评估。
共纳入 6529 名婴儿(3312 名男孩[50.7%])进行分析。其中,1381 名是早产儿(出生时平均[SD]胎龄为 34.4[0.1]周;5148 名是足月儿(出生时平均[SD]胎龄为 39.4[0]周)。在 1381 名早产儿中,确定了 8 种表型:未检测到主要的母体、胎儿或胎盘状况(485 名婴儿[35.1%]);感染(289 名婴儿[20.9%]);子痫前期(162 名婴儿[11.7%]);胎儿窘迫(131 名婴儿[9.5%]);宫内生长受限(110 名婴儿[8.0%]);严重的母体疾病(85 名婴儿[6.2%]);出血(71 名婴儿[5.1%]);和先天性异常(48 名婴儿[3.5%])。对于所有表型,先前的早产是复发的危险因素。每种表型在新生儿发病率和婴儿结局方面都存在差异。例如,未检测到主要疾病的婴儿发病率较低,但在 1 岁时发病率和住院发生率较高(比值比[OR],2.2;95%置信区间[CI],1.8-2.7)。与足月儿相比,在胎儿窘迫(OR,10.6;95%CI,5.1-22.2)表型的新生儿中,精细运动发育领域低于 INTER-NDA 正常参考值第 10 百分位的风险最高。
本研究结果表明,表型分类可能比继续将早产视为纯粹基于时间的实体更好地理解与早产相关的病因因素和机制。